Home Cart Sign in  
Chemical Structure| 70359-46-5 Chemical Structure| 70359-46-5

Structure of Brimonidine tartrate
CAS No.: 70359-46-5

Chemical Structure| 70359-46-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Brimonidine tartrate is an α-adrenergic receptor agonist with EC50 of 0.45 nM for the α2A adrenoreceptor, used to treat glaucoma through a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow.

Synonyms: AGN190342 tartrate; UK 14304 tartrate; Alphagan P

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Brimonidine tartrate

CAS No. :70359-46-5
Formula : C15H16BrN5O6
M.W : 442.22
SMILES Code : BrC1=C2N=CC=NC2=CC=C1NC3=NCCN3.O=C(O)[C@H](O)[C@@H](O)C(O)=O
Synonyms :
AGN190342 tartrate; UK 14304 tartrate; Alphagan P
MDL No. :MFCD07773072

Safety of Brimonidine tartrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Brimonidine tartrate

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02039765 Hyperemia PHASE1 COMPLETED 2025-04-14 Bausch & Lomb, Incorporated, R... More >>ochester, New York, 14609, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.26mL

0.45mL

0.23mL

11.31mL

2.26mL

1.13mL

22.61mL

4.52mL

2.26mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories